Vaccinating premature infants in a Special Care Baby Unit in the UK: Results of a prospective, non-inferiority based, pragmatic case series study

Human Vaccines

Volumn 6, Issue 6, 2010, Pages 512-520

  Baxter, David ^a   Ghebrehewet, Sam ^b   Welfare, William ^b   Ding, Dau C D ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Chester Microbiology Laboratory   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Immunization; Premature infant; Special care baby unit

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ARTICLE; DIPHTHERIA; HAEMOPHILUS INFECTION; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; PNEUMOCOCCAL INFECTION; PREMATURITY; TETANUS; UNITED KINGDOM; VACCINATION;

EID: 77956683746     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.6.6.11448     Document Type: Article

References (32)

1. Baxter D. Vaccine responsiveness in premature infants. Human Vaccines 2010; 6: In press.
2. Baxter D. Impaired functioning of immune defences to infection in premature and term infants and their implications for vaccination. Human Vaccines 2010; 6: In press.
3. Booy R, Aitken SJ, Taylor S, Tudor-Williams G, Macfarlane JA, Moxon ER, et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months versus 3, 5 and 9 months of age. Lancet 1992; 339:507-10.
4. Smith JW. Diptheria and tetanus toxoids. Br Med Bull 1969; 177-82.
5. Levine L, Ipsen J, McComb J. Adult immunization. Preparation and evaluation of combined fluid tetanus and diphtheria toxoids for adult use. Am J Hyg 1961; 73:20-35.
6. Ipsen J Jr. Inherent immunizability to tetanus toxoid, based on studies in pure bred mice. J Immunol 1954; 72:243-7.
7. Tasman A, Huygen FJ. Immunization against tetanus of patients given injections of antitetanus serum. Bull World Health Organ 1962; 26:397-407.
8. Ruggeberg JU, Collins C, Clarke P, Johnson N, Sinha R, Everest N, et al. Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants. Vaccine 2007; 25:264-71.
9. Kitchin NR, Southern J, Morris R, Hemme F, Thomas S, Watson MW, et al. Evaluation of a diphtheriatetanus- acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age. Arch Dis Child 2007; 92:11-6.
10. Vazquez L, Garcia F, Ruttimann R, Coconier G, Jacquet JM, Schuerman L. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatrica 2008; 97:1243-9.
11. Berrington JE, Fenton AC, Cant AJ, Spickett GP, O'Keeffe M, Matthews JN. Reduced anti-PRP antibody response to Hib immunisation in preterm (<32 weeks) UK infants who received inactivated polio (eIPV). Vaccine 2007; 25:8206-8.
12. Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose. Pediatrics 2006; 117:717-24.
13. Slack MH, Schapira D, Thwaites RJ, Burrage M, Southern J, Andrews N, et al. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis- Haemophilus influenzae type b conjugate vaccines. Journal of Infectious Diseases 2001; 184:1617-20.
14. 197 conjugate vaccine administered 3, 5 and 11 months post-natally to preand full-term infants. Vaccine 2007; 25:4889-94.
15. Saji F, Samejima Y, Kamiura S, Koyama M. Dynamics of immunoglobulins at the feto-maternal interface. Rev Reprod 1999; 4:81-9.
16. Siegrist CA. The Challenges of Vaccine Responses in Early Life: Selected Examples. J Comp Pathol 2007; 137:4-9.
17. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003; 21:3406-12.
18. Siegrist CA. Neonatal and early life vaccinology. Vaccine 2001; 19:3331-46.
19. 197 conjugate vaccine mixed with chitosan. Infect Immun 2005; 73:8256-65.
20. Maslanka SE, Gheesling LL, Libutti DE, Donaldson KB, Harakeh HS, Dykes JK, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin Diagn Lab Immunol 1997; 4:156-67.
21. Andrews N, Borrow R, Miller E. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin Diagno Lab Immunol 2003; 10:780-6. (Pubitemid 37129487)
22. Lal G, Balmer P, Stanford E, Martin S, Warrington R, Borrow R. Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Methods 2005; 296:135-47.
23. Quataert SA, Kirch CS, Wiedl LJ, Phipps DC, Strohmeyer S, Cimino CO, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin Diagn Lab Immunol 1995; 2:590-7.
24. D'Angio CT. Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy and tolerability. Paediat Drugs 2007; 9:17-32.
25. Cates KL, Goetz C, Rosenberg N, Pantschenko A, Rowe JC, Ballow M. Longitudinal development of specific and functional antibody in very low birth weight premature infants. Pediat Res 1988; 23:14-22. (Pubitemid 18053504)
26. Seppala IJ, Routonen N, Sarnesto A, Mattila PA, Makela O. The percentages of six immunoglobulin isotypes in human antibodies to tetanus toxoid: standardization of isotype-specific second antibodies in solid-phase assay. Eur J Immunol 1984; 14:868-75. (Pubitemid 14045924)
27. Seppala IJ, Makela O. Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens. Immunology 1984; 53:827-36. (Pubitemid 15209940)
28. Lagergard T, Trollfors B, Claesson BA, Karlberg J, Taranger J. Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria. Eur J Clin Microbiol Infect Dis 1992; 4:341-5.
29. Bucholc B, Banach W. Distribution of IgG subclasses and their biological activity in bioglobulin. Medycyna Doswiadczalna i Mikrobiologia 1998; 50:105-13.
30. Beck OE. Distribution of virus antibody activity among human IgG subclasses. Clin Exp Immunol 1981; 43:626-32.
31. Makela O, Mattila P, Rautonen N, Seppala I, Eskola J, Kayhty H. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J Immunol 1987; 139:1999-2004.
32. Uddin S, Borrow R, Haeney MR, Moran A, Warrington R, Balmer P, et al. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity. Vaccine 2006; 24:5637-44. (Pubitemid 44172914)